Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Magnevist (Gadopentetate dimeglumine) - Important Safety Information from Bayer HealthCare as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
26/06/2007
Problem Or Issue:
Please find attached Safety Communication from Bayer HealthCare in respect of Magnevist (Gadopentetate dimeglumine) and Nephrogenic Systemic Fibrosis (NSF)
« Back
Date Printed: 19/04/2024